Scholar Rock (NASDAQ:SRRK) Reaches New 1-Year High – Should You Buy?

Scholar Rock Holding Corporation (NASDAQ:SRRK) shares reached a new 52-week high during trading on Friday . The stock traded as high as $48.28 and last traded at $46.2020, with a volume of 77686 shares traded. The stock had previously closed at $47.76.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on SRRK. UBS Group started coverage on Scholar Rock in a research report on Wednesday, January 7th. They set a “buy” rating and a $60.00 target price on the stock. JPMorgan Chase & Co. increased their price target on shares of Scholar Rock from $46.00 to $47.00 and gave the stock an “overweight” rating in a report on Tuesday, November 18th. Citigroup began coverage on shares of Scholar Rock in a report on Friday, January 9th. They set a “buy” rating and a $55.00 price objective on the stock. Wolfe Research initiated coverage on Scholar Rock in a report on Tuesday, November 18th. They issued an “outperform” rating and a $42.00 price objective on the stock. Finally, Truist Financial dropped their price target on Scholar Rock from $54.00 to $44.00 and set a “buy” rating for the company in a research report on Monday, October 20th. Four analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $50.14.

Scholar Rock Price Performance

The stock has a market cap of $4.72 billion, a PE ratio of -14.67 and a beta of 0.63. The company has a debt-to-equity ratio of 0.41, a quick ratio of 6.30 and a current ratio of 6.30. The stock’s 50-day moving average is $43.59 and its two-hundred day moving average is $37.24.

Scholar Rock (NASDAQ:SRRK) last issued its quarterly earnings data on Friday, November 14th. The company reported ($0.90) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.88) by ($0.02). During the same quarter last year, the business earned ($0.66) earnings per share. On average, equities analysts predict that Scholar Rock Holding Corporation will post -2.42 earnings per share for the current year.

Insider Buying and Selling at Scholar Rock

In other news, General Counsel Junlin Ho sold 8,016 shares of the firm’s stock in a transaction that occurred on Friday, January 16th. The shares were sold at an average price of $44.48, for a total value of $356,551.68. Following the completion of the transaction, the general counsel owned 214,553 shares of the company’s stock, valued at approximately $9,543,317.44. This trade represents a 3.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Mo Qatanani sold 8,406 shares of the company’s stock in a transaction that occurred on Friday, January 16th. The stock was sold at an average price of $44.48, for a total transaction of $373,898.88. Following the sale, the insider directly owned 100,558 shares in the company, valued at approximately $4,472,819.84. The trade was a 7.71% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 290,789 shares of company stock valued at $12,844,688. Corporate insiders own 13.30% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Newbridge Financial Services Group Inc. purchased a new stake in Scholar Rock during the 4th quarter worth about $132,000. StoneCrest Wealth Management Inc. boosted its stake in shares of Scholar Rock by 24.7% in the 4th quarter. StoneCrest Wealth Management Inc. now owns 59,003 shares of the company’s stock valued at $2,494,000 after buying an additional 11,671 shares during the period. Tema Etfs LLC increased its stake in shares of Scholar Rock by 6.6% during the fourth quarter. Tema Etfs LLC now owns 9,899 shares of the company’s stock worth $436,000 after buying an additional 616 shares during the period. Three Seasons Wealth LLC increased its stake in shares of Scholar Rock by 2.1% during the fourth quarter. Three Seasons Wealth LLC now owns 10,968 shares of the company’s stock worth $483,000 after buying an additional 222 shares during the period. Finally, SG Americas Securities LLC raised its holdings in Scholar Rock by 602.4% in the fourth quarter. SG Americas Securities LLC now owns 84,349 shares of the company’s stock valued at $3,716,000 after acquiring an additional 72,341 shares in the last quarter. 91.08% of the stock is currently owned by hedge funds and other institutional investors.

Scholar Rock Company Profile

Scholar Rock is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that selectively target growth factors involved in disease processes. The company’s research platform is designed to modulate endogenous growth factor activation and signaling with high specificity, aiming to restore normal biological function across a range of disorders. Scholar Rock’s approach is distinguished by its emphasis on engineering antibodies and biologics that interact with growth factor precursors or latent complexes rather than the active form, potentially offering improved safety and efficacy profiles.

The company’s lead program, SRK-015 (appercept), is an investigational monoclonal antibody targeting the activation of latent myostatin proproteins and is being evaluated for the treatment of spinal muscular atrophy (SMA).